Finance

Lists
Why is 001060 up 3,69%?
Dive Deeper
001060:KRX
JW Pharmaceutical Corp
₩25 300,00
+3,69%
(+900,00) 1D
16 Okt., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001060...
Open
₩24 500
High
₩25 550
Low
₩24 500
Mkt. cap
607,55 mjd
Avg. vol.
53,58 k
Volume
33,07 k
Dividend
2,57%
Quarterly dividend
â‚©163
Ex-dividend date
27 Des. 2023
P/E ratio
6,03
52-wk high
₩39 250
52-wk low
₩21 550
EPS
₩4 193
Shares outstanding
23,29 m
No. of employees
1 k
Open
₩24 500
High
₩25 550
Low
₩24 500
Mkt. cap
607,55 mjd
Avg. vol.
53,58 k
Volume
33,07 k
Dividend
2,57%
Quarterly dividend
â‚©163
Ex-dividend date
27 Des. 2023
P/E ratio
6,03
52-wk high
₩39 250
52-wk low
₩21 550
EPS
₩4 193
Shares outstanding
23,29 m
No. of employees
1 k
News stories
From web sources and news partners
About JW Pharmaceutical Corp
CEOLee, Kyung Ha
Employees1,05 k
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
200,02 mjd
198,94 mjd
199,88 mjd
222,02 mjd
Cost of goods sold
105,39 mjd
109,09 mjd
101,43 mjd
116,73 mjd
Cost of revenue
105,39 mjd
109,09 mjd
101,43 mjd
116,73 mjd
Research and development expenses
7,33 mjd
15,27 mjd
9,38 mjd
11,86 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 mjd
60,42 mjd
55,91 mjd
59,90 mjd
Operating expense
62,60 mjd
80,98 mjd
64,88 mjd
71,95 mjd
Total operating expenses
167,99 mjd
190,07 mjd
166,31 mjd
188,68 mjd
Operating income
32,03 mjd
8,87 mjd
33,58 mjd
33,34 mjd
Other non operating income
-4,64 mjd
8,03 mjd
1,21 mjd
835,27 m
EBT including unusual items
27,85 mjd
17,49 mjd
35,20 mjd
34,76 mjd
EBT excluding unusual items
27,85 mjd
15,96 mjd
35,20 mjd
34,76 mjd
Income tax expense
-2,74 mjd
2,18 mjd
7,72 mjd
6,86 mjd
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 mjd
15,32 mjd
27,48 mjd
27,89 mjd
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 k
-
-
-
Interest and investment income
-
3,34 mjd
-
-
Interest expense
-
-4,42 mjd
-
-
Net interest expenses
-
-1,09 mjd
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 mjd
13,65 mjd
38,56 mjd
38,37 mjd
Gain or loss from assets sale
5,12 m
3,00 k
-10,00 m
3,00 k
AI content may include mistakes. Learn more
Google-programme